📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Melinta

1.1 - Company Overview

Melinta Logo

Melinta

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of antibiotics, developing and commercializing antibiotics to overcome drug-resistant infections.

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Melinta

Agenovir Logo

Agenovir

HQ: United States Website
  • Description: Provider of novel antiviral therapeutics for diseases associated with viral reservoirs.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Agenovir company profile →
Mymetics Logo

Mymetics

HQ: Switzerland Website
  • Description: Provider of virosome-based vaccine R&D and immunotherapies, focused on next-generation preventative vaccines for infectious diseases. Pipeline includes HIV-1/AIDS, intranasal influenza, malaria, herpes simplex virus and RSV, plus candidates for Covid-19 and COP allergy immunotherapy, and research collaborations in cancer immunotherapy. Swiss-based with a research lab in the Netherlands.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Mymetics company profile →
MYR Pharma Logo

MYR Pharma

HQ: Germany Website
  • Description: Provider of biotechnological treatments focused on hepatitis B and hepatitis D.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full MYR Pharma company profile →
Eiger BioPharmaceuticals Logo

Eiger BioPharmaceuticals

HQ: United States Website
  • Description: Provider of biopharmaceutical therapies, including lonafarnib, an oral farnesyl-transferase inhibitor blocking Hepatitis Delta Virus replication; avexitide, a GLP-1 receptor antagonist for post-bariatric hypoglycemia and congenital hyperinsulinism; Zokinvy (lonafarnib) for Hutchinson-Gilford Progeria Syndrome and processing-deficient Progeroid Laminopathies; and an Expanded Access Program.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Eiger BioPharmaceuticals company profile →
Pharmasset Logo

Pharmasset

HQ: United States Website
  • Description: Provider of novel oral therapeutics to treat viral infections, with a primary focus on hepatitis B (HBV), hepatitis C (HCV), and human immunodeficiency virus (HIV). Clinical-stage pharmaceutical company committed to discovering, developing, and commercializing antiviral drugs.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Pharmasset company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Melinta

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Melinta

2.2 - Growth funds investing in similar companies to Melinta

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Melinta

4.2 - Public trading comparable groups for Melinta

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Melinta

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Melinta

What does Melinta do?

Melinta is a provider of antibiotics, developing and commercializing antibiotics to overcome drug-resistant infections.

Who are Melinta's competitors?

Melinta's competitors and similar companies include Agenovir, Mymetics, MYR Pharma, Eiger BioPharmaceuticals, and Pharmasset.

Where is Melinta headquartered?

Melinta is headquartered in United States.

How many employees does Melinta have?

Melinta has 1,000 employees 🔒.

When was Melinta founded?

Melinta was founded in 2010 🔒.

What sector and industry vertical is Melinta in?

Melinta is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Melinta

Who are the top strategic acquirers in Melinta's sector and industry

Top strategic M&A buyers and acquirers in Melinta's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Melinta?

Top strategic M&A buyers groups and sectors for Melinta include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Melinta's sector and industry vertical

Which are the top PE firms investing in Melinta's sector and industry vertical?

Top PE firms investing in Melinta's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Melinta's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Melinta's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Melinta's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Melinta include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Melinta's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Melinta?

The key public trading comparables and valuation benchmarks for Melinta include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Melinta for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Melinta with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Melinta's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Melinta with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Melinta's' sector and industry vertical?

Access recent funding rounds and capital raises in Melinta's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Melinta